Pfiz­er, No­var­tis jump in­to an $84M de­vel­op­ment round for UK can­cer drug stars at Ar­tios

Can­cer hasn’t lost its siz­zle for biotech in­vestors.

VCs at Pfiz­er and No­var­tis have jumped in­to an $84 mil­lion round for Ar­tios, a Cam­bridge …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.